Outcomes of mild-to-moderate postresuscitation shock after non-shockable cardiac arrest and association with temperature management: a post hoc analysis of HYPERION trial data
Post-hoc analysis
Targeted temperature management
DOI:
10.1186/s13613-022-01071-z
Publication Date:
2022-10-17T14:09:13Z
AUTHORS (28)
ABSTRACT
Abstract Background Outcomes of postresuscitation shock after cardiac arrest can be affected by targeted temperature management (TTM). A post hoc analysis the “TTM1 trial” suggested higher mortality with hypothermia at 33 °C. We performed a HYPERION trial data to assess potential associations linking non-shockable °C on favourable functional outcome. Methods divided patients into groups vs. without (defined as need for vasoactive drugs) then assessed proportion outcome (day-90 Cerebral Performance Category [CPC] 1 or 2) (33 °C) controlled normothermia (37 in each group. Patients norepinephrine epinephrine > µg/kg/min were not included. Results Of 581 included 25 ICUs France and who did withdraw consent, 339 had 242 not. In postresuscitation-shock group, 159 received hypothermia, including 14 day-90 CPC 1–2, 180 normothermia, 10 1–2 (8.81% 5.56%, respectively; P = 0.24). After adjustment, also differ significantly between (adjusted hazards ratio, 1.99; 95% confidence interval, 0.72–5.50; 0.18). Day-90 was comparable these two (83% 86%, 0.43). Conclusions arrest, mild-to-moderate intensive-care-unit admission seem associated survival. Therapeutic worse outcomes compared shock. Trial registration ClinicalTrials.gov, NCT01994772
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (37)
CITATIONS (3)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....